Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,182 across all filing types
Latest filing 2021-08-10 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2021.
Interim / Quarterly Report Classification · 100% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the approval and disclosure of unaudited standalone and consolidated financial results for the quarter ended June 30, 2021. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulations 30, 33, and 47, which pertain to disclosure of quarterly financial results. The document includes detailed financial tables showing revenue, expenses, profit before tax, tax expenses, and net profit for the quarter ended June 30, 2021, along with comparative figures for previous quarters and the full fiscal year. It also mentions the Limited Review Reports by the statutory auditors for these quarterly results. The presence of unaudited quarterly financial results and the context of the filing clearly indicate this is an Interim / Quarterly Report. The document is substantive and contains actual financial data, not merely an announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2021-08-10 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a communication from Lupin Limited to stock exchanges regarding the approval and publication of unaudited standalone and consolidated financial results for the quarter ended June 30, 2021. It references Regulations 30, 33, and 47 of the SEBI Listing Regulations, which pertain to disclosure of quarterly financial results. The document includes detailed financial tables showing revenue, expenses, profit before tax, tax expense, and net profit for the quarter ended June 30, 2021, along with comparative figures for previous periods. It also mentions the Limited Review Reports by the statutory auditors for these quarterly results. The presence of detailed financial data and the quarterly period indicates this is a quarterly financial report. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2021-08-10 English
Intimation in respect of loss of share certificate.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015. It provides details of a lost share certificate and a request for stop transfer. The content is a regulatory notification related to share certificate handling and does not contain financial data, management discussion, or report content. It is a regulatory compliance filing notifying the exchange about share certificate issues, fitting the category of Regulatory Filings (RNS). The document length is short and it is not a report or announcement of a report publication.
2021-08-09 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015, addressed to the National Stock Exchange of India. It details the loss of share certificates and requests stop transfer, which is a regulatory compliance matter related to share certificate handling. The document is short (1479 characters) and serves as a formal notification or certificate rather than a financial report or announcement of financial results. It does not contain financial data, management discussion, or report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2021-08-09 English
Intimation in respect of loss of share certificate by the shareholder.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015, regarding details of loss of share certificates and a request for stop transfer. It is addressed to the stock exchange and contains details about share certificates and shareholders. The document is short (1725 characters) and is a regulatory announcement related to share certificates, not a financial report or detailed filing. It does not contain financial statements or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-08-03 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is very short (423 characters) and contains details about the loss of share certificates under Regulation 39(3). It lists certificate numbers, distinctive numbers, shareholder name, folio, and number of shares. This is a specific regulatory announcement related to share certificates, not a financial report or meeting material. It does not contain financial data, management discussion, or voting results. It fits best under Regulatory Filings (RNS) as a miscellaneous regulatory announcement.
2021-08-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.